New Therapeutics for Traumatic Brain Injury

Nitric Oxide Synthase Inhibitors in Traumatic Brain Injury

Introduction Since the identification of the gas nitric oxide (NO) as the endothelial-derived relaxing factor, NO has increasingly been recognized as being involved in numerous physiological and pathophysiological processes, in particular those related to inflammation and blood flow. NO can…

Perispinal Etanercept for Traumatic Brain Injury

Background Introduction Traumatic brain injury (TBI) is a leading cause of disability throughout the world ( ). An estimated 3.2–5.3 million Americans (1.1–1.7%) live with long-term mental and/or physical impairments as a result of TBIs ( ). Due to an…

Atorvastatin in the Treatment of Traumatic Brain Injury

Introduction Statins are a widely used class of medications which are inhibitory analogs of the enzyme β-hydroxy-β-methylglutaryl coenzyme A (HMG CoA) reductase. While very extensively used for treatment of hyperlipidemia and in the prevention of cardiovascular disease, their application to…